Languages: English - Digital Collections - National Library of Medicine Search Results

Start Over Languages English ✖ Publication Year 2021 ✖

641. The public’s perspective on the United States public health system

Publication:: [Princeton, New Jersey] : Robert Wood Johnson Foundation, May 2021
Subject(s):: Delivery of Health Care
Public Health
Public Opinion
United States

642. Observational real-world evidence update: prophylaxis of hereditary angioedema with Takhzyro and C1 inhibitors : effectiveness and value

Author(s):: Bloudek, Lisa, author
Jaksa, Ashley, author
McKenna, Avery, author
Carlson, Josh, author
Chen, Yilin, author
Patrick, Amanda, author
Campbell, Jon D., author
Publication:: [Boston, Massachusetts] : Institute for Clinical and Economic Review, August 24, 2021
Subject(s):: Angioedemas, Hereditary -- prevention & control
Complement C1 Inhibitor Protein
United States

643. Bempedoic acid and inclisiran for patients with heterozygous familial hypercholesterolemia and for secondary prevention of ASCVD: final policy recommendations

Publication:: [Boston, Massachusetts] : Institute for Clinical and Economic Review, March 2, 2021
Subject(s):: Cardiovascular Diseases -- prevention & control
Cholesterol, LDL -- antagonists & inhibitors
Hypercholesterolemia -- drug therapy
United States

644. Anti B-cell maturation antigen CAR T-cell and antibody drug conjugate therapy for heavily pre-treated relapsed and refractory multiple myeloma: final policy recommendations

Publication:: [Boston, Massachusetts] : Institute for Clinical and Economic Review, May 11, 2021
Subject(s):: Immunoconjugates
Immunotherapy, Adoptive
Multiple Myeloma
United States

645. JAK inhibitors and monoclonal antibodies for the treatment of atopic dermatitis: final policy recommendations

Publication:: [Boston, Massachusetts] : Institute for Clinical and Economic Review, August 17, 2021
Subject(s):: Antibodies, Monoclonal
Dermatitis, Atopic
Janus Kinase Inhibitors
United States

646. Treatments for anemia in chronic kidney disease: final policy recommendations

Publication:: [Boston, Massachusetts] : Institute for Clinical and Economic Review, March 5, 2021
Subject(s):: Anemia -- drug therapy
Renal Insufficiency, Chronic
United States

647. Mavacamten for hypertrophic cardiomyopathy: effectiveness and value : final evidence report and meeting summary

Author(s):: Wasfy, Jason H., author
Walton, Surrey M., author
Beinfeld, Molly, author
Nhan, Emily, author
Sarker, Jyotirmoy, author
Whittington, Melanie D., author
Pearson, Steven D., author
Rind, David M., author
Publication:: [Boston, Massachusetts] : Institute for Clinical and Economic Review, November 16, 2021
Subject(s):: Cardiac Myosins -- antagonists & inhibitors
Cardiomyopathy, Hypertrophic -- drug therapy
United States

648. Tezepelumab for severe asthma: final report

Author(s):: Rind, David M., author
McQueen, Brett, author
Herron-Smith, Serina, author
Herce-Hagiwara, Belén, author
Gutierrez, Éric, author
Fluetsch, Noemi, author
Pearson, Steven D., author
Publication:: [Boston, Massachusetts] : Institute for Clinical and Economic Review, December 16, 2021
Subject(s):: Antibodies, Monoclonal, Humanized
Asthma -- drug therapy
United States

649. Aducanumab for Alzheimer’s disease: effectiveness and value

Author(s):: Lin, Grace A., author
Whittington, Melanie D., author
Synnott, Patricia G., author
McKenna, Avery, author
Campbell, Jon, author
Pearson, Steven D., author
Rind, David M., author
Publication:: [Boston, Massachusetts] : Institute for Clinical and Economic Review, August 5, 2021
Subject(s):: Alzheimer Disease -- drug therapy
Antibodies, Monoclonal
United States

650. Acute treatments for migraine: final policy recommendations

Publication:: [Boston, Massachusetts] : Institute for Clinical and Economic Review, February 25, 2020
Subject(s):: Migraine Disorders -- drug therapy
Tryptamines
United States

« Previous
Next »
1
2
…
61
62
63
64
65
66
67
68
69
70
71